Optogenetic therapy holds promise for treatment of late-stage geographic atrophy
Click Here to Manage Email Alerts
BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Jordi Monés, MD, PhD, discusses an investigational optogenetic therapy for geographic atrophy.
Monés said retina specialists have been involved in many revolutions, and optogenetics promises to be the next, thanks to the new ambient light-activated therapies developed by Nanoscope Therapeutics.
One application of optogenetics is for the treatment of advanced geographic atrophy (GA). In this treatment, laser-activated nanoparticles of gold are used to selectively target the area of atrophy.
“This is something that will be in clinical trial hopefully soon to give another option to these very late-stage GA patients,” Monés said.
Collapse
Healio Interviews
Read more about
Click Here to Manage Email Alerts